9th Annual Biomarkers Congress

Peptides: Genentech

Total Score People Score Events Score
17 14 12
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Domagoj Vucic
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Peter K Jackson
January 12, 2011 Antibodies for the 21st Century Endogenous Anti-IFNa Autoantibodies in Patients with Systemic Lupus Erythematosus are Associated with Decreased IFN-Pathway and Disease Activity Alyssa Morimoto
May 17, 2010 Phage and Yeast Display of Antibodies and Proteins Chairperson’s Opening Remarks Sachdev Sidhu
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Synthetic PDZ Domains for Functional Genomics Sachdev Sidhu
Antibody Fragments and Scaffolds Sachdev Sidhu
December 7, 2008 Antibody Engineering Highly Functional Minimalist Antibodies Sachdev Sidhu
April 30, 2008 Assessment of Immunogenicity in Clinical Trials Case Study –Risk-based Immunogenicity Valerie Quarmby
April 28, 2008 Clinical Development of Therapeutic Antibodies The Development of Antiangiogenics in Lung Cancer Jane Huang
April 27, 2008 Phage Display of Antibodies and Peptides Chairperson’s Remarks Dev Sidhu
Synthetic Antibodies Germaine Fuh
April 27, 2008 Phage Display of Antibodies and Peptides Synthetic Antibodies Germaine Fuh
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Analysis of Protein Glycosylation (10:45-13:25) An Song
Analysis of Protein Glycosylation:Anticipating Effects of Glycosylation on Effector Functions (10:45-11:15) An Song
Causes and Assessment of Product and Process-Related Impurities (13:25-18:30) Fred Jacobson
Causes and Assessment of Product and Process-Related Impurities:Protein Aggregation and Bioprocessing (13:30-14:00) Fred Jacobson
Early Formulation Development (08:15-09:15) Jim Andya
Early Formulation Development: Early Development Screening of Monoclonal Antibody Formulations (08:15-08:45) Jim Andya
Process and Analytical Related Issues (15:30-17:00) Ron Taticek
Process and Analytical Related Issues: Quality by Design in the Development of Post-Approval Changes for Cell Culture Processes (15:30-16:00) Ron Taticek
November 7, 2007 Antibodies Europe: Engineering the Next Generation of Antibodies Nov (07-08) Engineering Therapeutics (10:00-11:30) Robert Kelley
Engineering Therapeutics: Fc Engineering of Therapeutic Antibodies (10:00-10:30) Robert Kelley
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00) Mark S. Dennis
Session 7: Tumor Targeting with an AB.Fab (09:00-09:20) Mark S. Dennis
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.